PortfolioMatthias Schwab
Personendaten
Akademischer Titel:
PD Dr.
Name:
Matthias Schwab
Einrichtungen:
Medizinische Fakultät
Universität Tübingen
Exzellenzcluster: Individualisierung von Tumortherapien durch molekulare Bildgebung und funktionelle Identifizierung therapeutischer Zielstrukturen (iFIT)
Zentren oder interfakultäre wissenschaftliche Einrichtungen
Graduiertenkolleg: Nicht-kanonische G-Protein-abhängige Signalwege
Graduiertenkollegs
Kontaktdaten
Lebenslauf
Academic Education and Degrees
| 1983 - 1990 | Study of medicine, Friedrich-Alexander University Erlangen Nürnberg, Germany |
| 1991 | M.D., Institute of Toxicology & Pharmacology, University Erlangen, Germany |
| 1996 / 2000 | Board Certification: Pediatrics and Adolescent Medicine / Clinical Pharmacology |
| 2003 | Habilitation, Clinical and Pediatric Pharmacology, University Tübingen, Germany |
Scientific Career and Positions
| since 2015 | Coopted Professor at the Faculty of Mathematics and Natural Sciences, Department of Pharmacy and Biochemistry, Eberhard Karls University Tübingen, Germany |
| since 2007 | Professor & Chair of Clin. Pharmacology, University Tübingen and Director of the Dr Margarete Fischer-Bosch Institute of Clin. Pharmacology, Stuttgart, Germany |
| 2001 - 2005 | Senior physician & Head of the Research of Clinical Trial Unit and Drug Information, Dr Margarete Fischer-Bosch Institute of Clin. Pharmacology, Stuttgart, Germany |
| 2005 - 2006 | Visiting Professor, St. Jude Children’s Research Hospital, Department of Pharmaceutical Sciences, Memphis, Tennessee, USA |
| 1995 - 2001 | Fellow in clinical pharmacology, Dr. Margarete Fischer-Bosch Institute of Clin. Pharmacology, Stuttgart, Germany |
| 1990 - 1995 | Civilian service and fellow in pediatrics / Senior house officer, University Hospital of Children and Adolescents, University Erlangen-Nürnberg, Germany |
Awards
| 2015 + 2016/17 | Thomson Reuters Highly Cited Researchers, rubric “Pharmacology and Toxicology” |
| 2016 | Robert-Pfleger Research Award |
| 2015 | “Staufermedaille in Gold” by the Prime Minister of Baden Württemberg |
| 2014 | Member of the German National Academy of Sciences ‘Leopoldina’ |
| 2013 | Most cited German pharmacologist in Europe (LabTimes, 2013) |
| 2012 | Full Member of the Academy of Science and Literature, Mainz, Germany |
| 2009 | Most cited pharmacologist in German-speaking countries (Laborjournal, 2009) |
| 2005 | Galenus von Pergamon Award |
| 2004 | Friedrich Hartmut Dost Award |
| 1983 - 1990 | Scholarship according to the "Bayerischen Begabtenförderungsgesetz" |
Memberships: Editorial Boards and Societies
| 2015 | President of the German Society of Exp. and Clin. Pharmacology and Toxicology |
| since 2014 | Member and Chair, Commission for Medical Research, Academy of Science and Literature Mainz, Germany |
| since 2013 | Chair, German Society of Clinical Pharmacology (DGKliPha) |
| since 2010 | Executive Board member and vice chair (2014-2018) of the Drug Metabolism and Transporter Section, Intern. Union of Basic and Clinical Pharmacology (IUPHAR) |
| since 2010 | Executive Committee, European Association of Clin. Pharmacology and Therapy |
| since 2008 | Section Editor PGx & Personalized Medicine of Genome Medicine |
| since 2007 | Editor-in-Chief of Pharmacogenetics & Genomics |
| since 2004 | Full Member & Vice Chair, Expert Group "Drugs for Children & Adolescents", BfArM |
Patente
04.04.2019
Lusine Danielyan, Christoph Gleiter, Matthias Schwab
Gayane Buniatian, Ralf Weiskirchen, Thomas Weiss
12.04.2019
Jens Bedke, Matthias Schwab, Arnulf Stenzl
Florian Büttner, Arndt Hartmann, Elke Schäffeler, Stefan Winter
27.08.2012
Lusine Danielyan, Christoph Gleiter, Barbara Proksch, Matthias Schwab
Projekte
2020 - 2022
Oliver Kohlbacher
Bundesministerium für Bildung und Forschung (BMBF)
2019 - 2025
Lars Zender, Bernd Pichler, Hans-Georg Rammensee
Deutsche Forschungsgemeinschaft e.V. (DFG)